Sino Biopharmaceutical (HK:1177) has released an update.
Sino Biopharmaceutical Limited has announced a Board meeting scheduled for August 13, 2024, to discuss and approve the publication of the company’s unaudited interim results for the first half of the year and to consider the declaration of an interim dividend. The upcoming Board meeting signals potential upcoming developments for shareholders and investors of the pharmaceutical company. The company’s management team and board comprise a mix of executive and independent non-executive directors.
For further insights into HK:1177 stock, check out TipRanks’ Stock Analysis page.
